Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seems to be percolating again. Does anybody know the reason for the latest signs of life? Or at least have some solid speculation? I always think that these moves are based on the simple fact that EKSO is massively under valued. But that doesn’t really explain anything... oh well, just glad I beefed up again under $5. I just firmly believe in the technology. Happy Thanksgiving!
I must admit that I’ve been nibbling away again building my share count. Under 5 seemed too much of a bargain to pass up. As for the funding, at least they set the $6.75 minimum. I believe in the technology, simple as that for me at this point in time.
It’s percolating once again... I was really encouraged by yesterday’s tweet regarding the 80% reduction in injuries at Ford. Another success story
I must say that this has been an exciting ride of late! It took the sale of 57% of the shares that I held to eke out a nice profit (but far from spectacular). So I’m now rolling, free of charge, with the remaining 43% and will hold tight to at least above $30 a share. That share price correlates to a company market cap below $230 million, which I believe is attainable in the near term. Of course another quick pop might cause me to fold like a cheap suit... Ever since that CFIUS decision which caused the termination of the Chinese Joint Venture I’ve been daydreaming about a substantial government contract. I’m also hopeful large institutions have invested in EKSO now that we’ve remained above $5 per share. After the reverse split we’ve been left with such a small total share count, even after we recapitalized, and it was a sight to see the entire float turnover at least 10 times in one day. Who know what tomorrow will bring, I’m going to be ready with some popcorn.
You certainly hit the nail on the head... I guess it was to be expected, but dilution is never pleasant. I hope this offering brought aboard some worthwhile institutions and that this fund raise covers whatever cost might be associated with untangling the Chinese JV and keeps them afloat for quite awhile. The feds need to have a good reason for the CFIUS decision and that reason better include a DOD contract!
What a nice feeling to no longer ponder whether I should buy more to decrease my average price per share... Now, pretty please, stay above $5.00 and let heavyweight institutional buyers take heed and come aboard!
Porsche, the way I see it is the price action in the recent past had a lot to do with the ability by nefarious actors (shorts sellers and their ilk) to manipulate Ekso’s stock price because it’s a “penny” stock. Please let this stock soon rise above $5 and let’s get the institutions aboard. A rise to $5 would only require a market cap of around $29,200,000. Come on, that should be easily attainable. One good quarter where we close the sales lost due to Covid and we’re back in the game at a much higher price. Add in any meaningful government contract and we become the second American company to head into orbit this year. I know I sound optimistic, but I am. As for today, a close above $4 would be a pleasantry.
I do love the news. Don’t know the source, but sure do like the message. I decided to go all in after the split and, thus far, I’m glad that I did. This is a solid company with excellent products for today and the future. The blow we took from the CIFIUS determination to not allow the joint venture may be a blessing in disguise. In my most rosy daydream the government came down so hard because they want to use Ekso’s technology on their military exoskeleton application. A man can dream...
Dilution always hurts... Having acknowledged that, I must say I was pleased that both the execution and timing of this public offering were spot on. Getting that offer closing press release out today was a great relief. Now any funding concerns are in the rear view mirror, we have a long holiday weekend to enjoy, and a fresh new day for business on Tuesday.
EAs it’s earnings day once again, I can’t help but check back in even though I have nothing substantive to add... I’m just excited about the future and still feel very comforted by the China deal which took any further dilution off the table in the near term and should add monumentally to the bottom line down the road - without an additional dollar spent. I do realize that they’ve already posted preliminary numbers, but it’s the guidance that has me intrigued. Do we hear more details about the China partnership? How’s the new production facility in China coming along? And do we have a better idea do what it means for margins? How about the Task vest in Japan? What’s the scoop on the government contract secured on the last day of the fiscal year (for the feds)?
So much happening! I even envision some secret skunks works team that is moving ahead full steam on a home Ekso GT for direct to consumer sales. My last rhetorical question, are you a “pumper” if you’ve put your money where your mouth is regurgitating? Obviously I’m excited for the conference call.
I’m hoping for that $5+ range as well. In the interim, this deal certainly took away a great deal of the risk usually involved with such a small company. It will be very interesting to hear them discuss this partnership at the next quarterly conference call.
Agree, this may well be the game changer! Does anybody know how to translate this agreement to its impact on price per share? I can’t seem to understand an appropriate formula.
It seems you were right on with your call of “oversold.” We’ve had a nice rebound in price and I’m not aware of any news. Perhaps something is in the wind as well...
I’m sure that you’re right about putting together a price rally with singles and an occasional double. Right now it seems we have the bottom of the order at bat, but the top of the order is imminent! My search didn’t unearth anything not already posted about the VA contract. However, the timing of the contract, utilizing “sole source”, and having such a quick closing window reminds of how federal contracts get awarded at the end of the fiscal year (which is Sept. 30) when contracting officials want to ensure that they’ve spent their entire yearly budget. In the federal government budgeting can be odd, basically if you don’t spend you’re entire budget you put yourself at risk of having your budget cut the next fiscal year. So, my mind has wondered towards the thought that perhaps this was a quick year end purchase they need to execute by Sept. 30. Obviously, this is just my speculation.
Quick question for those more knowledgeable folks on board. Will the revenue from the VA contract be included in the 3rd quarter? I’m starting to get excited about about the possibility of a homerun for the quarterly revenue and need a reality check..
I've been pondering Ekso Bionics lately and here's the byproduct of an online anonymous mind... To start, I certainly expected a drop in price during this time period because of the expired one year window for Puissance and the tax status change (to long term) for regular shareholders who took advantage of the offering from Ekso last year. You can count me as one of the folks who participated in the offering and I did so by matching all my shares. Further, when I read that Puissance was willing to hold for one year at a dollar I made (for me) a huge additional purchase of shares. To my great relief, that risk has been rewarded. Over the past year I halved my position during the two price spikes and have about a 35% profit plus the remainder of my shares (which is still a substantial position) which are "free riding." So, for me, the pressure is off on this investment.
BUT! Like everyone else, I would like to make money on the shares I hold regardless of past events. So, what does the future hold? I wish I knew, but i just don't. However, I thought I would share my thoughts going forward. To start, the biggest question is where does the price stabilize without any news of substance. Again, I wish I knew. What I do know is that if the price action takes a dive, I'm buying. Not exactly sure at what level, but I'll add to my position. The reason I'm doing that is rather mundane and it's simply because I've been very comforted by the quarterly reports. To my thinking, they are steadily building the EKSO GT business. The last few quarters have seen increasing sales and leases, and the user base seems solid and resolved to continue with this new method of treating stroke and spinal injury patients. I truly believe that is a trend that will continue and when insurance and other factors come into play it may become a more exponential growth story.
I'm getting tired of writing, so I'll add all the other items that could boost this company and it's stock:
1. The industrial business has seen great success over a very short time period. While there is competition, the untapped market potential is enormous.
2. Government contracts? Where will this lead? The VA contract was a HUGE get
3. My active imagination wonders what's happening with a home use Exoskeleton. It is very easy to imagine that they're far down the road on this monster market, but are smart enough not to share this information until they've got a wonderfully functional and elegant product completed.
We all know that exoskeletons will be commonplace in the future and everything that Ekso has done over the past year makes me believe they will be one of the companies who benefits.
Thanks for the spot on response. I’m just holding here as Puissance and other shareholders take some profits as they should (they have more than doubled over the past year). I do admit that I find it a bit concerning that there are so many legitimate players in the construction market. I’m really glad we have the two strong verticals with our healthcare line.
In regard to the Ottobock exoskeleton selected by BMW do you think it would fall under the Ekso/ Ottobock licensing agreement? I Just don’t know the scope of that arrangement.
It appears that my glasses are rose colored... I really like the results from last quarter. A good revenue figure with solid sales in both medical and industrial and a backlog of orders. I do realize that we’re still burning cash at too high a rate, but we appear to have built a real foundation and I think sales will continue to grow quarter over quarter. Also opening new markets in Asia.
What would be awesome is if, somehow, EKSO was able to release a home use exoskeleton in conjunction with the joint educational outreach with the national stroke association… Here’s language from the press release:
“The partnership will coincide with National Stroke Awareness Month, in May, and Stroke and Technology Month, in November, when the national spotlight will be on developments in technologies that provide post-stroke independence and improved health outcomes.”
I must admit that I really do like this news, very much. However, I have no idea what it means for the share price short term. What excites me is that this partnership, with an established national stroke association, provides Eksobionics with credibility within that community. Also, it seems that by partnering on this education, the National Stroke Association endorses the Ekso GT. I think that this implied endorsement may provide a needed boost to EKSO’s sales team. Just my take...
Random thoughts… First, like everyone else, I’m awaiting the exciting news. I assume that it has to do with the medical side because the tweet ended with “#Stroke.” My second thought has to do with the removal and replacement of Looby with Peurach so unexpectedly (at least to me). I keep thinking (based only on my imagination)that Li and Puissance was the force behind the change due to disagreement on how to steer the company to profitability. Perhaps their disagreement had to do with entry into China and potential partnerships? BRING ON THE NEWS!
FYI - Motley Fool mention: https://finance.yahoo.com/news/3-top-stocks-under-5-120400674.html
How come no options on EKSO? They had been available prior to the November expiration. If we get another run up I would like the comfort provided by purchasing some protective puts. I just don’t want to sell anymore shares until the pps becomes a bit more magnificent.
Is there a “back of the envelope“ method to determine the average price per share for current stock holders? I’ve been pondering this question since the recent runner-up. Basically, I’ve been in EKSO for many years, but also had the good fortune to buy-in substantially during the rights offering and after. So, prior to the run, my brokerage shares had been at an average price per share of 3.05 and my recently purchased IRA shares were at 1.18. I did sell a 1/3 of both positions which has put me in an extremely low risk position to hold until EKSO has the time to fully implement their plans and reap the financial benefit.
I figure that there is a longer term core group that are holding somewhere around the 3 to 5 price range and if they didn’t sell during this past run up, then they will most likely hold until this runs to a higher price point. Then you have the 34 million shares held by Puissance with the obligation to not sell any shares for a full year. So, they obviously believe and their shares are dormant for the moment. And then we have the recent folks who just discovered EKSO and now are holding at around the 2 to 4 range. Finally, I’m assuming that the momentum and day traders have exited their positions during the past few trading days and that wildcard is soon removed from the deck (at least until more news is released...). So, is it reasonable to believe that many shareholders would be disinclined to sell below 2.5? Or, is that just a ridiculous assumption based on completely anecdotal musings.
I’m trying to look at price per share from a different angle and don’t have as much faith in charts when it comes to such small cap stocks. Appreciate any random thoughts or condemnations.
Ford Pilots New Exsoskeleton Technology. Link:
https://media.ford.com/content/fordmedia/fna/us/en/news/2017/11/09/ford-exoskeleton-technology-pilot.html?mkt_tok=eyJpIjoiTVRRNE5tUTVOR1kwWkdFNSIsInQiOiJORzdUREVOK0xCQlpTVXZhVlN6Uno0WlRQXC9va3lSQkczZW1ycXBmRVM5YXN1eHJUWWdDdUtwVW9tdVp3UHlRV2ZqQVFCckZOUHYxanNiWVZ1aFwvT1ZMNDErUFE4SmduN1ZTUUR2b3UycGQ4ck50bEk0MURxbU5tSFg4ZURibVArIn0%3D
EKSO QUARTERLY RESULTS. Based on my WAG, out of thin air analysis, I think that EKSO will post a minimum of a 20% sales increase for both the medical and industrial sectors. I’m also encouraged by their recent patent for a lightweight home use eksoskeleton (also hoping for a discussion on going to market and FDA approval track for home use). Finally, it’s time to get the EksoVest officially on the market with a nice PR.
As you can tell, I’m excited about the quarterly results and the conference call. Please talk me down if I’m way out of line with my imaginary results...
On my TD Ameritrade account I had a a very concise news alert come across that included this link to the patent and trade office.
http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=9,801,772&OS=9,801,772&RS=9,801,772
The news snippet seem to indicate that the brief bump up of the share price earlier was due to this document floating around the investment community. I hope the link works...
Good day fellow Eksobionics investors. I'm writing just to say hello after having just joined this board. I'm actually quite pleased to have found a message board that seems to have a fairly robust following for EKSO. I'm very much invested in this stock and the future of this company AND extremely concerned with the stock performance lately. I must admit that I fully subscribed to the latest offering and doubled my position, while halving my average price per share, but I'm still well under water. However, I am quite hopeful for a strong third quarter performance. It's my belief that, as this technology becomes better understood by the potential client base, the pace of sales will increase dramatically. At this point it still seems as if the education required during the sales process remains quite daunting.
Hopefully, the many studies that they've initiated will provide all the hard data required to shorten and enhance the sales cycle. I'm also fascinated by the industrial side of the equation, but don't really understand the potential there (it seems huge, but I just don't know).
I look forward to learning from you all.